Coloplast A/S (OTCMKTS:CLPBY) Stock Passes Below 50 Day Moving Average – Should You Sell?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $7.98 and traded as low as $7.00. Coloplast A/S shares last traded at $7.12, with a volume of 473,515 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Coloplast A/S Stock Up 1.3%

The firm has a 50-day moving average of $7.98 and a two-hundred day moving average of $8.67. The stock has a market capitalization of $16.05 billion, a price-to-earnings ratio of 26.37, a price-to-earnings-growth ratio of 0.71 and a beta of 0.33. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Friday, February 6th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%.The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.12 billion. As a group, sell-side analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.